Profil
Mira Leiwant is Senior VP-Quality, Regulatory & Clinical Affairs at Anika Therapeutics, Inc. since 2019.
Former roles include Senior Director-Regulatory & Quality Engineering at LifeCell Corp.
and Vice President-Regulatory Affairs at BTG International, Inc. Education includes undergraduate and graduate degrees from Cornell University, conferred in 1997 and 1998 respectively.
Aktive Positionen von Mira Leiwant
| Unternehmen | Position | Beginn |
|---|---|---|
| ANIKA THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 14.10.2019 |
Ehemalige bekannte Positionen von Mira Leiwant
| Unternehmen | Position | Ende |
|---|---|---|
BTG International, Inc.
BTG International, Inc. Investment ManagersFinance BTG International invests in companies located in the United States. The firm targets companies operating in the fields of the biopharmaceutical, medical devices, multimedia, networking and nanotechnology sectors. It provides financing for seed and early stage capital requirements. | General Counsel | - |
LifeCell Corp.
LifeCell Corp. BiotechnologyHealth Technology Develops and markets tissue repair products | Corporate Officer/Principal | - |
Ausbildung von Mira Leiwant
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
LifeCell Corp.
LifeCell Corp. BiotechnologyHealth Technology Develops and markets tissue repair products | Health Technology |
Anika Therapeutics, Inc.
Anika Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair | Health Technology |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BTG International, Inc.
BTG International, Inc. Investment ManagersFinance BTG International invests in companies located in the United States. The firm targets companies operating in the fields of the biopharmaceutical, medical devices, multimedia, networking and nanotechnology sectors. It provides financing for seed and early stage capital requirements. | Finance |
















